Evidence map›Paper›PMID 27600110›Full record

ArticleZeitschrift fur Rheumatologie2017

Fatigue in systemic lupus erythematosus : Association with disease activity, quality of life and psychosocial factors.

S Yilmaz-Oner, B Ilhan, M Can, F Alibaz-Oner, O Polat-Korkmaz, G Ozen, G Mumcu, H M Kremers, S Tuglular, H Direskeneli

Abstract read
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Rheumatologie, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Living with Systematic Lupus Erythematosus: A Profile of Young Female Patients.International journal of environmental research and public health · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

S Yilmaz-OnerSchool of Medicine, Department of Rheumatology, Marmara University, 34890, Pendik Istanbul, Turkey. sibely113@gmail.com.
B IlhanSchool of Medicine, Marmara University, Istanbul, Turkey.
M CanSchool of Medicine, Department of Rheumatology, Marmara University, 34890, Pendik Istanbul, Turkey.
F Alibaz-OnerSchool of Medicine, Department of Rheumatology, Marmara University, 34890, Pendik Istanbul, Turkey.
O Polat-KorkmazSchool of Medicine, Marmara University, Istanbul, Turkey.
G OzenSchool of Medicine, Department of Rheumatology, Marmara University, 34890, Pendik Istanbul, Turkey.
G MumcuFaculty of Health Sciences, Department of Health Management, Marmara University, Istanbul, Turkey.
H M KremersCollege of Medicine, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
S TuglularSchool of Medicine, Department of Nephrology, Marmara University, Istanbul, Turkey.
H DireskeneliSchool of Medicine, Department of Rheumatology, Marmara University, 34890, Pendik Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of the study was to determine which disease-related factors and non-disease features can explain the presence of systemic lupus erythematosus (SLE)-related fatigue in Turkish patients.

methodsThis cross-sectional study was carried out with 99 SLE patients and 71 healthy controls. To assess fatigue and health-related quality of life (HRQoL) the participants were asked to complete two questionnaires: the short form-36 health survey (SF-36) and the multidimensional assessment of fatigue (MAF) scale. Anxiety and depression of participants were assessed by the hospital anxiety and depression scale (HADS).

resultsA total of 99 patients (female/male 95/4) and 71 controls (female/male 40/31) were studied. The mean age and standard deviation (±SD) of patients and controls were 43.3 ± 12.2 years and 43.2 ± 12.1 years, respectively. The mean (SD) disease duration was 7.8 ± 5.3 years and median SLE disease activity index (SLEDAI) score was 0 (range = 0-16). The level of fatigue was higher in patients compared to controls with mean MAF scores of 24.7 ± 12.2 and 12.8 ± 9.9 (p < 0.001), respectively. The HADS-D and HADS-A scores were also significantly higher in SLE patients (6.6 ± 4.3 vs. 3.6 ± 2.9, p < 0.001 and 7.2 ± 4 vs. 4.9 ± 4, p = 0.007, respectively). There were no significant associations between the MAF and SLEDAI scores (r = 0.05, p = 0.63) but MAF scores positively correlated with age, HADS-A and HADS-D scores and negatively correlated with physical component summary (PCS), mental component summary (MCS) and each domain of SF-36 except role emotional in SLE patients.

conclusionFatigue is an important factor influencing patient daily life independent from disease activity in our study. The SLE patients with severe fatigue should also be assessed for other possible underlying causes such as anxiety, depression and poor quality of life.

Indexed as

Activities of Daily LivingAdultAnxietyCross-Sectional StudiesDepressionFatigueFemaleHumansLupus Erythematosus, SystemicMaleMiddle AgedPsychologyQuality of LifeSurveys and QuestionnairesTurkeyAnxietyDepressionFatigueQuality of lifeSystemic lupus erythematosus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.